跳至主要内容
临床试验/NCT06599476
NCT06599476进行中(未招募)不适用

Use of Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy: a Prospective Clinical Study

Advanced Radiation Centers of New York2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年5月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
150
试验地点
2
主要终点
Dosimetry

研究概览

简要总结

This is a prospective clinical study involving up to 150 subjects with localized prostate cancer who are scheduled for radiation treatment with rectal spacer placement.

The goal of this clinical trial is to assess the safety and efficacy of perirectal spacers in patients undergoing radiation therapy for the treatment of localized prostate cancer.

Study visits:

  • Screening
  • Spacer placement
  • Treatment planning simulation
  • End of the radiation treatment
  • 1, 3, 6, 12, 18 and 24-months FU visits.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients with prostate cancer ≥ 18 years of age.
  • Patients are in one of the following risk groups:
  • T1-T3 prostate cancer with no posterior extra capsular extension
  • Gleason score ≤ 7
  • Planned for radiation treatment with rectal spacer.
  • Ability to understand and the willingness to sign a written informed consent form.

排除标准

  • Metastatic disease.
  • Previously treated localized adenocarcinoma of the prostate.
  • Active Inflammatory bowel disease requiring treatment with steroids.
  • Prior total prostatectomy.
  • Current urinary tract infection.
  • Acute or chronic prostatitis.

研究组 & 干预措施

BioProtect Balloon Implant System

Experimental

The Bio Protect Balloon Implant System (BioProtectLtd.,TzurYigal,Israel) is an Food and Drug Administration approved rectal spacer that consists of a solid biodegradable balloon-shaped material composed of poly L-Lactide-co-caprolactone

干预措施: BioProtect Balloon Implant™ System (Device)

结局指标

主要结局

Dosimetry

时间窗: 6 months

Dose-volume histogram (DVH) including the percent of the rectal volume receiving 70 Gy

次要结局

未报告次要终点

研究者

发起方
Advanced Radiation Centers of New York
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shawn Zimberg, MD

Dr Shawn Zimberg, Radiation Oncology Medical Director, Radiation Oncology

Advanced Radiation Centers of New York

研究点 (2)

Loading locations...

相似试验

Rectal Spacers in Prostate Cancer Patients... | 临床试验